Isabell Brikell receives "Rising Star Award" from ACAMH

According to the organisation, the ACAMH Awards aim to recognise high quality work in evidence based science, both in publication and practice, in the field of child and adolescent mental health. To be nominated for an ACAMH Award is a prestigious recognition of those who are at the forefront of the advancement of child and adolescent mental health research, and practice. Isabell Brikell who is Assistant Professor at the Department of Medical Epidemiology and Biostatistics was very honoured to be nominated and shortlisted for the ACAMH award. 

Why did you receive the award?

"The award is given for a significant scientific contribution to child and adolescent mental health literature, within 10 years of their first peer reviewed journal publication.

Since publishing my first scientific article in 2015, I have been doing research that aims to bridge psychiatric epidemiology and genetics to better understand the clinical heterogeneity in ADHD and move towards improved treatment. I have led studies focused on neurological comorbidity in ADHD, and on how ADHD genetic liability relates to both psychiatric and somatic comorbidity, risk-factors, and the diverse clinical presentation of ADHD across the lifespan.  This involves integrating advanced epidemiological designs with family and molecular genetic data to enhance understanding of ADHD."

 What does the award mean to you?

"To be recognized by ACAMH is a great honour, and I am especially happy to see that the work I have been doing for the past nearly 10 years is deemed as important and relevant for child and adolescent mental health by a multidisciplinary organization like ACAMH that gathers both clinicians and researcher in the field."